Clinical Trial

Phase 2b Controlled Study

Completed Phase 2
View on ClinicalTrials.gov →
Summary
Double-masked two period controlled trial of three eyelid wipe dosing techniques
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-18; most recent amendment 2026-03-24.
Status change: Active, Not Recruiting → Completed 2026-03-24
Status change: Recruiting → Active, Not Recruiting 2025-09-09
Trial Details
NCT Number NCT07140380
Lead Sponsor IVIEW Therapeutics Inc.
Conditions Dry Eye Disease
Enrollment 30 participants
Start Date 2025-08-20
Primary Completion 2025-10-08 (estimated)
Study Completion 2025-10-08 (estimated)
Updated on ClinicalTrials.gov 2026-03-27